Drugs
-
Information for Lantus (insulin glargine)
Lantus is a long-acting modified version of human insulin (insulin analog) used to control blood sugar in patients with Type 1 and Type 2 diabetes.
To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.
-
Related Information
FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
1/12/2011- FDA Drug Safety Podcast: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
Early Communication About Safety of Lantus (insulin glargine)
7/1/2009
-
Contact FDA
1-800-332-1088
1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20857
-
-